NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

“Majority” means enough of the application is with the publisher to initiate their cross checks for:

quality control checking of citations, numbers, cross-references, formatting and the like, in preparation for the submission.

The application can’t be reviewed for the above listed items if it’s not, for the most part, complete. As I understand it, the “majority” means just that… there was enough of it submitted as of 11/23 that the above describe publisher tasks could begin. And the remaining bit would be submitted shortly thereafter and would be rolled into the “several weeks” process cited by Northwest… and not increase that timeline.

Hopefully that will remain the case, but the publisher’s work is their work, and so, too, is the several week estimate. I would think, however, that the “acquiring publisher” is fully aware of the delays Northwest has incurred, and are working as diligently as possible to come as close to the “several weeks” timeline as possible.